Anti-HLA-DRA (MHC II) Antibody BHA10201859

Mfr.No.	3122-MSM3-P1ABX
Alternative Names	DR alpha chain ; HLA class II histocompatibility antigen ; HLA class II histocompatibility antigen DR alpha chain ; HLA DRA ; HLA DRA1 ; HLA-DRA ; HLADRA1 ; Major histocompatibility complex class II DR alpha ; MHC cell surface glycoprotein ; MHC class II antigen DRA
Categories	Primary Antibodies
Cellular Localization	Cell Surface
Chromosome Location	6p21.3
Clonality	Monoclonal
Description	This MAb reacts with the HLA-DR antigen, a member of MHC class II molecules. It does not cross react with HLA-DP and HLA-DQ. HLA-DR is a heterodimeric cell surface glycoprotein comprised of a 36kDa alpha (heavy) chain and a 28kDa beta (light) chain. It is expressed on B-cells, activated T-cells, monocytes/macrophages, dendritic cells and other non-professional APCs. In conjunction with the CD3/TCR complex and CD4 molecules, HLA-DR is critical for efficient peptide presentation to CD4+ T cells. It is an excellent histiocytic marker in paraffin sections producing intense cytoplasmic staining. True histiocytic neoplasms are similarly positive. HLA-DR antigens also occur on a variety of epithelial cells and their corresponding neoplastic counterparts.
Host	Mouse
Immunogen	Raji cells
Isotype	IgG2a Kappa
Positive Control	Ramos, Daudi or HuT78 cells. Tonsil or lymph node
Reactivity	Human
Recombinant	FALSE
Regulatory	RUO

Swissprot	P01903
Uniprot	520048
Gene Id	3122

Buffer	200μg/ml of Ab purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.
Concentration	1.0mg/ml
Description	There are no warranties, expressed or implied, which extend beyond this description. Company is not liable for any personal injury or economic loss resulting from this product.
Purity	Purified Ab WITHOUT BSA and Azide at 1.0mg/ml

Applications

FACS, IF, IHC-F

Description

(Staining of formalin-fixed tissues is enhanced by boiling tissue sections in 10mM Citrate Buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes); Optimal dilution for a specific application should be determined., FACS ; IF ; IHC-F

Dilution

FACS	0.5-1μg/million cells in 0.1ml
IF	0.5-1μg/ml
IHC-F	1-2μg/ml for 30 minutes at RT

Have you used this product?

Rate it now..!!

SKU	Supplier No.	Size	Your price	Quantity
BHA10201859	3122-MSM3-P1ABX	100µg	$393.20		Add to Cart

Anti-HLA-DRA (MHC II) Antibody BHA10201859

Contact us to order

Tel

Email

Contact us to order

Tel

Email

Reviews of Anti-HLA-DRA (MHC II) Antibody BHA10201859

Rate it now..!!